List of Tables
Table 1. Global Approved COVID-19 Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Approved COVID-19 Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Approved COVID-19 Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Approved COVID-19 Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Approved COVID-19 Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Approved COVID-19 Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Approved COVID-19 Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Approved COVID-19 Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Approved COVID-19 Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Approved COVID-19 Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Approved COVID-19 Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Approved COVID-19 Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Approved COVID-19 Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Approved COVID-19 Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Approved COVID-19 Vaccines Sales by Region (2020-2025) & (K Units)
Table 18. Global Approved COVID-19 Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Approved COVID-19 Vaccines Sales by Region (2026-2031) & (K Units)
Table 20. Global Approved COVID-19 Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Approved COVID-19 Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Approved COVID-19 Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Approved COVID-19 Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Approved COVID-19 Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Approved COVID-19 Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Approved COVID-19 Vaccines Sales by Country (2020-2025) & (K Units)
Table 27. North America Approved COVID-19 Vaccines Sales by Country (2026-2031) & (K Units)
Table 28. North America Approved COVID-19 Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Approved COVID-19 Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Approved COVID-19 Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Approved COVID-19 Vaccines Sales by Country (2020-2025) & (K Units)
Table 32. Europe Approved COVID-19 Vaccines Sales by Country (2026-2031) & (K Units)
Table 33. Europe Approved COVID-19 Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Approved COVID-19 Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Approved COVID-19 Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Approved COVID-19 Vaccines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Approved COVID-19 Vaccines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Approved COVID-19 Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Approved COVID-19 Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Approved COVID-19 Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Approved COVID-19 Vaccines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Approved COVID-19 Vaccines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Approved COVID-19 Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Approved COVID-19 Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Approved COVID-19 Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Approved COVID-19 Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Approved COVID-19 Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Approved COVID-19 Vaccines Sales (K Units) by Type (2020-2025)
Table 51. Global Approved COVID-19 Vaccines Sales (K Units) by Type (2026-2031)
Table 52. Global Approved COVID-19 Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Approved COVID-19 Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Approved COVID-19 Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Approved COVID-19 Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Approved COVID-19 Vaccines Price (US$/Unit) by Type (2020-2025)
Table 59. Global Approved COVID-19 Vaccines Price (US$/Unit) by Type (2026-2031)
Table 60. Global Approved COVID-19 Vaccines Sales (K Units) by Application (2020-2025)
Table 61. Global Approved COVID-19 Vaccines Sales (K Units) by Application (2026-2031)
Table 62. Global Approved COVID-19 Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Approved COVID-19 Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Approved COVID-19 Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Approved COVID-19 Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Approved COVID-19 Vaccines Price (US$/Unit) by Application (2020-2025)
Table 69. Global Approved COVID-19 Vaccines Price (US$/Unit) by Application (2026-2031)
Table 70. Moderna Company Information
Table 71. Moderna Description and Business Overview
Table 72. Moderna Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Moderna Approved COVID-19 Vaccines Product
Table 74. Moderna Recent Developments/Updates
Table 75. CanSino Biologicals Company Information
Table 76. CanSino Biologicals Description and Business Overview
Table 77. CanSino Biologicals Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. CanSino Biologicals Approved COVID-19 Vaccines Product
Table 79. CanSino Biologicals Recent Developments/Updates
Table 80. Inovio Pharmaceuticals Company Information
Table 81. Inovio Pharmaceuticals Description and Business Overview
Table 82. Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Inovio Pharmaceuticals Approved COVID-19 Vaccines Product
Table 84. Inovio Pharmaceuticals Recent Developments/Updates
Table 85. Shenzhen Geno-Immune Medical Institute Company Information
Table 86. Shenzhen Geno-Immune Medical Institute Description and Business Overview
Table 87. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product
Table 89. Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
Table 90. GlaxoSmithKine Company Information
Table 91. GlaxoSmithKine Description and Business Overview
Table 92. GlaxoSmithKine Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. GlaxoSmithKine Approved COVID-19 Vaccines Product
Table 94. GlaxoSmithKine Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Pfizer Approved COVID-19 Vaccines Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Johnson&Johnson Company Information
Table 101. Johnson&Johnson Description and Business Overview
Table 102. Johnson&Johnson Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Johnson&Johnson Approved COVID-19 Vaccines Product
Table 104. Johnson&Johnson Recent Developments/Updates
Table 105. Heat Biologics Company Information
Table 106. Heat Biologics Description and Business Overview
Table 107. Heat Biologics Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Heat Biologics Approved COVID-19 Vaccines Product
Table 109. Heat Biologics Recent Developments/Updates
Table 110. Sanofi Company Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Sanofi Approved COVID-19 Vaccines Product
Table 114. Sanofi Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Approved COVID-19 Vaccines Distributors List
Table 118. Approved COVID-19 Vaccines Customers List
Table 119. Approved COVID-19 Vaccines Market Trends
Table 120. Approved COVID-19 Vaccines Market Drivers
Table 121. Approved COVID-19 Vaccines Market Challenges
Table 122. Approved COVID-19 Vaccines Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Approved COVID-19 Vaccines
Figure 2. Global Approved COVID-19 Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Approved COVID-19 Vaccines Market Share by Type: 2024 & 2031
Figure 4. Component Viral Vaccines Product Picture
Figure 5. Whole Virus Vaccines Product Picture
Figure 6. Global Approved COVID-19 Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Approved COVID-19 Vaccines Market Share by Application: 2024 & 2031
Figure 8. Adults
Figure 9. Children
Figure 10. Elderly
Figure 11. Global Approved COVID-19 Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Approved COVID-19 Vaccines Market Size (2020-2031) & (US$ Million)
Figure 13. Global Approved COVID-19 Vaccines Sales (2020-2031) & (K Units)
Figure 14. Global Approved COVID-19 Vaccines Average Price (US$/Unit) & (2020-2031)
Figure 15. Approved COVID-19 Vaccines Report Years Considered
Figure 16. Approved COVID-19 Vaccines Sales Share by Manufacturers in 2024
Figure 17. Global Approved COVID-19 Vaccines Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Approved COVID-19 Vaccines Players: Market Share by Revenue in Approved COVID-19 Vaccines in 2024
Figure 19. Approved COVID-19 Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Approved COVID-19 Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Approved COVID-19 Vaccines Sales Market Share by Country (2020-2031)
Figure 22. North America Approved COVID-19 Vaccines Revenue Market Share by Country (2020-2031)
Figure 23. United States Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Approved COVID-19 Vaccines Sales Market Share by Country (2020-2031)
Figure 26. Europe Approved COVID-19 Vaccines Revenue Market Share by Country (2020-2031)
Figure 27. Germany Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Approved COVID-19 Vaccines Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Approved COVID-19 Vaccines Revenue Market Share by Region (2020-2031)
Figure 34. China Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Approved COVID-19 Vaccines Sales Market Share by Country (2020-2031)
Figure 44. Latin America Approved COVID-19 Vaccines Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Approved COVID-19 Vaccines Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Approved COVID-19 Vaccines Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Approved COVID-19 Vaccines by Type (2020-2031)
Figure 55. Global Revenue Market Share of Approved COVID-19 Vaccines by Type (2020-2031)
Figure 56. Global Approved COVID-19 Vaccines Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Approved COVID-19 Vaccines by Application (2020-2031)
Figure 58. Global Revenue Market Share of Approved COVID-19 Vaccines by Application (2020-2031)
Figure 59. Global Approved COVID-19 Vaccines Price (US$/Unit) by Application (2020-2031)
Figure 60. Approved COVID-19 Vaccines Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed